000 02439cam a2200229 4500500
005 20250112021256.0
041 _afre
042 _adc
100 1 0 _aSaliou, Philippe
_eauthor
700 1 0 _a Urbes, Florence
_eauthor
700 1 0 _a Fouquet, Claire
_eauthor
700 1 0 _a Branchu, Florence
_eauthor
700 1 0 _a Rozan, Hind
_eauthor
700 1 0 _a Derycke, Tristan
_eauthor
700 1 0 _a Colot, Julien
_eauthor
245 0 0 _aMicrobiological monitoring of endoscopes as an element of quality assurance at the Centre Hospitalier Territorial in New Caledonia between 2012 and 2020
260 _c2022.
500 _a98
520 _aBackground. Flexible endoscopes are complex, non-autoclavable devices that must undergo high-level disinfection. The presence of dirt and biofilms can cause infection and encourage the spread of resistance to antibiotics. Microbiological monitoring of endoscopes is recommended in France but remains controversial internationally. The objective of this study is to assess the contribution of this monitoring as an element of quality assurance in New Caledonia. Method. We reviewed all the microbiological tests carried out on flexible endoscopes between January 1, 2012 and December 31, 2020 at the Centre Hospitalier Territorial (CHT) in New Caledonia. We assessed the contamination rate and identified the main microorganisms isolated. Results. 605 microbiological endoscope controls were analyzed. A total of 87 samples (14.4%) did not reach the target level. The non-compliance rate varied from 25.0 % to 4.5 % depending on the year. Choledochoscopes and echoendoscopes were the most contaminated devices (p = 0.0035). The main microorganisms identified were gram-positive bacteria such as coagulase-negative staphylococci (n = 122) and Micrococcus sp (n = 97), and gram-negative bacteria including Moraxella sp (n = 31) and Pseudomonas (n = 17). Conclusion. This study evaluated the effectiveness of the disinfection of flexible endoscopes used at the CHT. The overall contamination rate (14.4%) is in line with the figures published in various studies. This monitoring makes it possible to identify deviations in the disinfection process and to take corrective measures that ensure patient safety.
786 0 _nAnnales de Biologie Clinique | 80 | 2 | 2022-03-01 | p. 126-132 | 0003-3898
856 4 1 _uhttps://shs.cairn.info/journal-annales-de-biologie-clinique-2022-2-page-126?lang=en
999 _c135245
_d135245